Healthcare Investors

Covalence Health partners with investors throughout the deal lifecycle—from initial sourcing and due diligence through post-acquisition value creation. Our team brings over 250 years of collective healthcare experience across payers, providers, technology companies, and policy environments, enabling us to evaluate potential investments with the nuanced understanding that only comes from working inside these systems. We help investors move quickly and confidently through deal sourcing by identifying emerging opportunities, conducting thorough market analysis and competitive landscape assessments, and providing realistic valuations grounded in operational realities rather than theoretical models. Our expertise spans the full healthcare ecosystem—from clinical workflows and reimbursement mechanics to regulatory compliance and stakeholder relationships—allowing us to spot both hidden risks and untapped opportunities that surface-level analysis misses.

The US healthcare system's complexity cannot be understood through data analysis alone, and this is where human expertise becomes irreplaceable. AI tools can process information, but they cannot replicate the judgment that comes from navigating CMS rule changes, understanding how different payer contracts actually work in practice, or recognizing why a promising technology might fail at the point of provider adoption. Covalence Health's value to investors lies in this deep contextual knowledge: we understand how reimbursement models influence market adoption, how regulatory shifts create or destroy competitive advantages, and how operational realities in clinical settings determine whether innovations succeed or stall. After the deal closes, we work alongside portfolio companies to accelerate growth, refine go-to-market strategies, navigate compliance requirements, and build the strategic partnerships necessary to scale in an industry where relationships and credibility matter as much as the product itself.